Using cell mass to determine response to treatment: A possible cure?
Novel ALL treatment strategies: CAR T-cells
What’s next for inotuzumab ozogamicin in ALL?
Exploring the potential of T-cell therapy for acute lymphoblastic leukemia
iwAL 2018 day 1 discussion: treatment strategies in pediatric and adult ALL
Charles Mullighan et al.